Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:physicist
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Von_Hippel-Lindau_syndrome
|
| gptkbp:affects |
both genders
|
| gptkbp:associated_with |
gptkb:healthcare_organization
gptkb:municipality gptkb:academic_journal patient education case studies patient outcomes risk assessment genetic research genetic predisposition psychosocial support family planning multidisciplinary approach patient support groups pneumothorax clinical management neoplasms long-term follow-up tumor suppressor gene renal tumors surveillance strategies Birt-Hogg-Dubé syndrome-associated tumors FLCN mutations chromosome 17p11.2 cutaneous manifestations cutaneous tumors genetic testing availability lung cysts multiple cysts pulmonary cysts spontaneous pneumothorax |
| gptkbp:caused_by |
skin tumors
|
| gptkbp:clinical_trial |
gptkb:stock_market_index
|
| gptkbp:current_use |
hereditary leiomyomatosis and renal cell cancer
|
| gptkbp:descendant |
autosomal dominant
|
| gptkbp:discovered_by |
Birt, Hogg, and Dubé
|
| gptkbp:first_described_by |
in 1977
|
| gptkbp:genetic_diversity |
recommended
|
| https://www.w3.org/2000/01/rdf-schema#label |
Birt-Hogg-Dubé syndrome
|
| gptkbp:is_popular_in |
rare
|
| gptkbp:promoter |
FLCN
|
| gptkbp:research |
ongoing
|
| gptkbp:risk_factor |
family history
mutation in FLCN gene |
| gptkbp:social_responsibility |
genetic testing
clinical evaluation |
| gptkbp:symptoms |
lipomas
fibrofolliculomas trichodiscomas |
| gptkbp:treatment |
surgical removal of tumors
monitoring for kidney cancer |